CRISPR gene editing is widely recognized as the most significant and groundbreaking breakthrough in life science since the 21st century. It was officially born in 2012 and was recognized by the Nobel Prize in just 8 years. At the end of last year, the first CRISPR based gene editing therapy was approved by the FDA…
01 FDA approved new gene editing therapy for the treatment of OTC deficiency in clinical practice On April 4, 2024, the FDA approved the clinical study approval application for ECUR-506 for the treatment of neonatal patients with ornithine aminotransferase (OTC) deficiency. OTC deficiency, also known as hyperammonemia type II, is an X-linked genetic disease caused…
Since the intensive progress in the field of gene editing therapy was released, it has to some extent boosted confidence in the industry. The attitude and actions of the FDA are key factors in promoting the commercialization of gene editing therapy. Since Feng Zhang first demonstrated in 2013 that CRISPR-SpCas9 can successfully perform gene editing…
Biobased Energy and Materials learned that recently, Dutch green chemical company Avantium announced that it will fully focus on the production and sales of FCDA and PEF technologies. It will stop investing in Ray technology for producing plantMEG (plant-based ethylene glycol) and plantMPG (plant-based propylene glycol) until suitable strategic equity partners are found. FDCA (Furanedicarboxylic…
At present, Spain has a large amount of biomass (olive leaves) that has not been fully utilized, but discarded olive leaves are rich in valuable bioactive compounds, giving them the opportunity to become a potential carbon source for various industries. The number of underutilized olive leaves is astonishing. Olive trees planted for the production of…
On November 8, 2023 Eastern Time, synthetic biology company Ginkgo Bioworks (NYSE: DNA, hereinafter referred to as Ginkgo) released its financial performance report for the third quarter of 2023. (Source: Company website) According to the company’s official website, Ginkgo’s total revenue in the third quarter of 2023 was $55 million, down from $66 million…